FAF
INSM icon

Fjarde Ap-fonden’s Insmed INSM Stock Holding History

Fjarde Ap-fonden’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.3M Buy
68,450
+100
+0.1% +$12.1K 0.03% 365
2026
Q1 		$11.2M Buy
68,350
+17,850
+35% +$2.74M 0.06% 268
2025
Q4 		$8.79M Buy
+50,500
New +$9.22M 0.07% 244

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Fjarde Ap-fonden's INSM Position: Q2 2026 in Review

Fjarde Ap-fonden increased its Insmed (INSM) stake by 0.15% in Q2 2026, buying an estimated $12.1K and bringing the position to 68,450 shares worth $7.3M. The position accounts for 0.03% of the portfolio, ranked #365.

Fjarde Ap-fonden first reported a position in INSM in Q4 2025 and has held it in 3 quarters since. The position peaked at $11.2M in Q1 2026. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Fjarde Ap-fonden held 68,450 shares of Insmed worth $7.3M as of Q2 2026.
  • Fjarde Ap-fonden bought 100 Insmed shares in Q2 2026, an estimated $12.1K.
  • Insmed made up 0.03% of Fjarde Ap-fonden's portfolio in Q2 2026, its #365 holding.
  • Fjarde Ap-fonden first reported a position in Insmed in Q4 2025 and has held it in 3 quarters since.
  • Fjarde Ap-fonden's Insmed position peaked at $11.2M in Q1 2026.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Fjarde Ap-fonden's 13F filing for Q2 2026, filed 29 Jul 2026.